Effect of ABCB1 haplotypes on the pharmacokinetics and renin-inhibiting effect of aliskiren

Tuija Tapaninen, Pertti J. Neuvonen, Mikko Niemi

Open source

DOI
10.1007/s00228-010-0836-z
Published
2010-05-23
Container
European Journal of Clinical Pharmacology
Publisher
Springer Science and Business Media LLC
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1007/s00228-010-0836-z,
  title = {Effect of ABCB1 haplotypes on the pharmacokinetics and renin-inhibiting effect of aliskiren},
  author = {Tuija Tapaninen and Pertti J. Neuvonen and Mikko Niemi},
  year = {2010},
  journal = {European Journal of Clinical Pharmacology},
  doi = {10.1007/s00228-010-0836-z},
  url = {https://doi.org/10.1007/s00228-010-0836-z}
}

RIS

TY  - JOUR
TI  - Effect of ABCB1 haplotypes on the pharmacokinetics and renin-inhibiting effect of aliskiren
AU  - Tuija Tapaninen
AU  - Pertti J. Neuvonen
AU  - Mikko Niemi
PY  - 2010
JO  - European Journal of Clinical Pharmacology
DO  - 10.1007/s00228-010-0836-z
UR  - https://doi.org/10.1007/s00228-010-0836-z
ER  - 

APA

Tapaninen, T., Neuvonen, P. J., & Niemi, M. (2010). Effect of ABCB1 haplotypes on the pharmacokinetics and renin-inhibiting effect of aliskiren. European Journal of Clinical Pharmacology. https://doi.org/10.1007/s00228-010-0836-z

Source records